Critics say a trade agreement now in the works between the European Union and India could make it harder for millions across the developing world to get lifesaving drugs.
Scientists at the Gladstone Institute of Virology and Immunology report on a new mechanism that governs the fat oxidation pathway and in the process identified a novel potential therapeutic target for controlling fat metabolism.
Gentronix has launched its early genotoxicity screening assay BlueScreen HC. This cell-based product enables accurate and reliable early identification of compounds likely to induce genotoxic stress and damage.
Absorption Systems, a leader in testing drugs for ADMET, has incorporated the Thermo Scientific LTQ Orbitrap XL Hybrid Fourier Transform mass spectrometer into its drug metabolism program.
Affymetrix, Inc. announced the launch of the Axiom Genome-Wide ASI Array, the first commercial product to provide maximum power for genome-wide association studies (GWAS) in East Asian populations.
Genetix, a leading provider of solutions for imaging and image analysis, announces that Vanderbilt Monoclonal Antibody Core (VMAC), Vanderbilt University, has become the 100th facility to purchase its ClonePix FL system.
Silence Therapeutics plc announces that the company and AstraZeneca have agreed to a one-year extension of their ongoing small interfering RNA (siRNA) delivery collaboration.
Vapourtec's R Series flow chemistry platform now supports use of the Gilson 215 liquid handler (autosampler) to feed reagents into reactions.
AB SCIEX announced that it is collaborating with the Samuel Lunenfeld Research Institute of Mount Sinai Hospital, one of the world’s leading centers for biomedical research, to improve disease studies.
The Uniqsis FlowSyn flow chemistry system has an upgraded pump manifold that continuously monitors each high pressure reagent channel and alerts the user to any flow abnormalities.
Syrris announced the release of Medstere, software for medicinal chemists that suggests novel bioisosteres for a lead compound.
Optibrium offers StarDrop 4.3, predictive modeling software that helps users to identify chemistries and guides compound selection and design decisions in all stages of drug discovery.
Amylin Pharmaceuticals, Inc., Eli Lilly and Company, and Alkermes, Inc. have submitted their reply to a complete response letter issued last month by the FDA after review of the new drug application submission for BYDUREON.
IDBS provides ChemJuice, a simple to use chemical structure drawing app for the iPhone and iPod touch.